Ikarian Capital »

Erasca shares owned by Ikarian Capital

Quarter-by-quarter ownership of Erasca (ERAS) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.7M 735k 3.72

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)
Spdr Series Trust State Street Spd Put Option (XBI)
Amgen (AMGN)
Terns Pharmaceuticals (TERN)
Abivax Sa Sponsored Ads (ABVX)
Harrow Health (HROW)
Rapt Therapeutics Com New (RAPT)
Cytokinetics Com New (CYTK)
Jazz Pharmaceuticals Call Call Option
Soleno Therapeutics (SLNO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Maze Therapeatics (MAZE)
Omeros Corporation Call Option (OMER)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Erasca

Frazier Life Sciences Management
VR Adviser
T. Rowe Price Investment Management
BlackRock
Suvretta Capital Management
Paradigm Biocapital Advisors
Logos Global Management
Vanguard Group
Arch Venture Corp
Vivo Capital
Siren
State Street Corporation
5AM Venture Management
Geode Capital Management
Affinity Asset Advisors

View all funds holding Erasca